Please login to the form below

Not currently logged in
Email:
Password:

Leo Pharma appoints new senior vice president

Rhonda Duffy will be responsible for global supply chain

Rhonda DuffyLeo Pharma has appointed Rhonda Duffy as its new senior vice president, global product supply, succeeding Jim McPherson in the process.

Duffy’s new role will see her take the helm of the Danish group’s global supply chain, a process that Duffy has experience in following her most recent role as vice president, dermatology value stream at Leo.

Gitte Aabo, president and chief executive officer of Leo Pharma, said: “Rhonda has extensive experience in pharmaceutical supply chain management, and she knows Leo Pharma really well.

“We are serving more than 80 million patients worldwide, are launching several products and have an ambitious pipeline and Rhonda is the right person to continue to optimise our operations and make it fit for the future.

Duffy initially joined Leo Pharma back in 1993 and was responsible for key parts of global product supply.

27th March 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...